Isolated nucleic acid molecule coding for tumor rejection antigen precursors MAGE-C1 and MAGE-C2 and uses thereof
    10.
    发明授权
    Isolated nucleic acid molecule coding for tumor rejection antigen precursors MAGE-C1 and MAGE-C2 and uses thereof 失效
    编码肿瘤排斥抗原前体MAGE-C1和MAGE-C2的分离的核酸分子及其用途

    公开(公告)号:US06475783B1

    公开(公告)日:2002-11-05

    申请号:US09066281

    申请日:1998-04-24

    IPC分类号: C12M1585

    CPC分类号: G01N33/56977 C07K14/4748

    摘要: The invention relates to isolated nucleic acid molecules which code for antigens expressed by tumor cells which maybe recognized by cytotoxic T cells, leading to lysis of the tumor cells which express it. This invention also relates to vectors which are designed to encode the antigen expressed by tumor cells and also to cells transfected by the nucleic acid molecules or vectors which comprise the nucleic acid molecules. Various therapeutic and diagnostic uses arising out of the properties of the nucleic acid molecules and the antigens for which these code are also part of this invention.

    摘要翻译: 本发明涉及分离的核酸分子,其编码由细胞毒性T细胞识别的肿瘤细胞表达的抗原,导致表达它的肿瘤细胞的裂解。 本发明还涉及被设计用于编码由肿瘤细胞表达的抗原以及由核酸分子转染的细胞或包含核酸分子的载体的载体。 由于这些代码也是本发明的一部分的核酸分子和抗原的性质引起的各种治疗和诊断用途。